HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN for Immunodeficiency common variable: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,598 adverse event reports in the FDA FAERS database where HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN was used for Immunodeficiency common variable.
Most Reported Side Effects for HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Sinusitis | 436 | 10.0% | 6 | 55 |
| Headache | 375 | 8.6% | 6 | 76 |
| Fatigue | 336 | 7.7% | 12 | 71 |
| Malaise | 259 | 5.9% | 19 | 77 |
| Pneumonia | 259 | 5.9% | 35 | 133 |
| Pyrexia | 249 | 5.7% | 23 | 88 |
| Death | 231 | 5.3% | 230 | 60 |
| Infusion site pain | 230 | 5.3% | 6 | 26 |
| Nausea | 223 | 5.1% | 9 | 54 |
| Covid-19 | 215 | 4.9% | 58 | 103 |
| Infusion site erythema | 213 | 4.9% | 8 | 26 |
| Pain | 200 | 4.6% | 9 | 48 |
| Infusion site swelling | 194 | 4.4% | 5 | 25 |
| Infusion site extravasation | 185 | 4.2% | 5 | 30 |
| Nasopharyngitis | 176 | 4.0% | 3 | 23 |
Other Indications for HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN
Primary immunodeficiency syndrome (1,055)
Product used for unknown indication (1,006)
Immunodeficiency (224)
Hypogammaglobulinaemia (162)
Selective igg subclass deficiency (136)
Secondary immunodeficiency (127)
Chronic lymphocytic leukaemia (35)
Immune system disorder (35)
Off label use (32)
Congenital hypogammaglobulinaemia (31)
Other Drugs Used for Immunodeficiency common variable
HUMAN IMMUNOGLOBULIN G (17,389)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (881)
GAMMAGARD LIQUID (81)
HIZENTRA (76)
DUPILUMAB (69)
RITUXIMAB (44)
INFLIXIMAB (28)
PREDNISOLONE (27)
HUMAN C1-ESTERASE INHIBITOR (24)
MYCOPHENOLATE MOFETIL (24)